CRS CRS Clinical Research Regulations 2 — Questions and Answers
Question 1: Phase I clinical trials primarily assess which of the following?
- Efficacy in large populations
- Long-term side effects
- Safety, tolerability, and dosage (Correct answer)
- Cost-effectiveness
Correct answer: Safety, tolerability, and dosage
Phase I trials focus on evaluating the safety, tolerability, and appropriate dosing of a new intervention in a small group of participants.
Question 2: What does 21 CFR Part 11 regulate in the context of clinical research?
- Informed consent procedures
- Electronic records and electronic signatures (Correct answer)
- IRB membership composition
- Drug manufacturing standards
Correct answer: Electronic records and electronic signatures
21 CFR Part 11 sets FDA requirements for the use of electronic records and electronic signatures in regulated clinical studies.
Question 3: An unexpected, fatal serious adverse event (SAE) in a clinical trial must be reported to the FDA within how many calendar days?
- 30 days
- 15 days
- 7 days (Correct answer)
- 48 hours
Correct answer: 7 days
Unexpected fatal or life-threatening serious adverse events must be reported to the FDA within 7 calendar days of the sponsor's knowledge.
Question 4: Which document outlines the objectives, design, methodology, and statistical considerations of a clinical trial?
- Investigator Brochure
- Study Protocol (Correct answer)
- Case Report Form
- Informed Consent Form
Correct answer: Study Protocol
The study protocol is the master document that describes the scientific rationale, objectives, and procedures for conducting a clinical trial.
Question 5: What is the role of a Sponsor in a clinical trial as defined by federal regulations?
- To treat enrolled patients
- To take responsibility for initiating, managing, and financing the trial (Correct answer)
- To conduct IRB reviews
- To publish final results
Correct answer: To take responsibility for initiating, managing, and financing the trial
The Sponsor is the entity that initiates, manages, and bears overall responsibility for the design, conduct, and regulatory compliance of a clinical trial.
Question 6: The Belmont Report established which three core ethical principles for human subjects research?
- Justice, transparency, and autonomy
- Respect for persons, beneficence, and justice (Correct answer)
- Safety, efficacy, and consent
- Privacy, equity, and fairness
Correct answer: Respect for persons, beneficence, and justice
The 1979 Belmont Report identified respect for persons, beneficence, and justice as the foundational ethical principles governing human subjects research.
CRS CRS Clinical Research Regulations 2
Phase I clinical trials primarily assess which of the following?